LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer

被引:27
作者
Hao, Longhui [1 ]
Wu, Wenzheng [1 ]
Xu, Yankun [1 ]
Chen, Yufan [2 ]
Meng, Chengzhen [2 ]
Yun, Jingyi [1 ]
Wang, Xiaoyu [1 ]
机构
[1] Shandong Univ Tradit Chinese Med, Coll Pharm, Jinan 250355, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan 250355, Peoples R China
来源
MOLECULES | 2023年 / 28卷 / 05期
基金
中国国家自然科学基金;
关键词
long non-coding RNA; lncRNA-MALAT1; cancer; mechanism; action pathway; LONG NONCODING RNA; LNCRNA MALAT1;
D O I
10.3390/molecules28052126
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
LncRNAs are a group of non-coding RNA transcripts with lengths of over 200 nucleotides and can interact with DNA, RNA, and proteins to regulate gene expression of malignant tumors in human tissues. LncRNAs participate in vital processes, such as chromosomal nuclear transport in the cancerous site of human tissue, activation, and the regulation of proto-oncogenes, the differentiation of immune cells, and the regulation of the cellular immune system. The lncRNA metastasis-associated lung cancer transcript 1 (MALAT1) is reportedly involved in the occurrence and development of many cancers and serves as a biomarker and therapeutic target. These findings highlight its promising role in cancer treatment. In this article, we comprehensively summarized the structure and functions of lncRNA, notably the discoveries of lncRNA-MALAT1 in different cancers, the action mechanisms, and the ongoing research on new drug development. We believe our review would serve as a basis for further research on the pathological mechanism of lncRNA-MALAT1 in cancer and provide evidence and novel insights into its application in clinical diagnoses and treatments.
引用
收藏
页数:14
相关论文
共 65 条
[51]   LncRNA参与转录后调控作用机制研究进展 [J].
杨旭 ;
訾晶晶 ;
郭宏 ;
丁向彬 ;
刘新峰 ;
张林林 .
天津农学院学报, 2022, 29 (02) :85-87+91
[52]   LncRNA CTD-3252C9.4 modulates pancreatic cancer cell survival and apoptosis through regulating IFI6 transcription [J].
Yin, Xin ;
Yang, Jingyan ;
Chen, Jintian ;
Ni, Ruiqi ;
Zhou, Yanhao ;
Song, Hao ;
Jin, Liang ;
Tang, Tingting ;
Pan, Yi .
CANCER CELL INTERNATIONAL, 2021, 21 (01)
[53]   Recent Advances in Predicting Protein-lncRNA Interactions Using Machine Learning Methods [J].
Yu, Han ;
Shen, Zi-Ang ;
Zhou, Yuan-Ke ;
Du, Pu-Feng .
CURRENT GENE THERAPY, 2022, 22 (03) :228-244
[54]  
[余良河 Yu Lianghe], 2010, [中国细胞生物学学报, Chinese Journal of Cell Biology], V32, P350
[55]  
Yu Q, 2020, THESIS CHENGDU U TRA, DOI [10.26988/d.cnki.gcdzu.2020.000101, DOI 10.26988/D.CNKI.GCDZU.2020.000101]
[56]  
Yue Z., 2017, J CLIN ENDOCR METAB, V57, P111
[57]  
Zeng Shu-Ying, 2021, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V29, P1763, DOI 10.19746/j.cnki.issn.1009-2137.2021.06.012
[58]   MALAT1 inhibits the Wnt/β-catenin signaling pathway in colon cancer cells and affects cell proliferation and apoptosis [J].
Zhang, Junjun ;
Li, Qian ;
Xue, Bing ;
He, Rui .
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2020, 20 (03) :357-364
[59]   LncRNA MALAT1 Modulates TGF-β1-Induced EMT in Keratinocyte [J].
Zhang, Liping ;
Hu, Junyi ;
Meshkat, Bahar I. ;
Liechty, Kenneth W. ;
Xu, Junwang .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
[60]  
Zhang M., 2022, Application of Malat1 Inhibitors in the Prevention and Treatment of Abdominal Aortic Aneurysms, Patent No. [CN202210163541.0, 2022101635410]